BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14555913)

  • 1. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease.
    Klebl FH; Bataille F; Bertea CR; Herfarth H; Hofstädter F; Schölmerich J; Rogler G
    Inflamm Bowel Dis; 2003 Sep; 9(5):302-7. PubMed ID: 14555913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.
    Ruemmele FM; Targan SR; Levy G; Dubinsky M; Braun J; Seidman EG
    Gastroenterology; 1998 Oct; 115(4):822-9. PubMed ID: 9753483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
    Lawrance IC; Murray K; Hall A; Sung JJ; Leong R
    Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
    Kim JE; Kim KS; Seo JK
    Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
    Esters N; Vermeire S; Joossens S; Noman M; Louis E; Belaiche J; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; Poulain D; Bossuyt X; Rutgeerts P;
    Am J Gastroenterol; 2002 Jun; 97(6):1458-62. PubMed ID: 12094865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
    Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
    Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
    Joossens S; Reinisch W; Vermeire S; Sendid B; Poulain D; Peeters M; Geboes K; Bossuyt X; Vandewalle P; Oberhuber G; Vogelsang H; Rutgeerts P; Colombel JF
    Gastroenterology; 2002 May; 122(5):1242-7. PubMed ID: 11984510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.